These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17455353)

  • 1. Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g).
    Descamps M; Willart JF; Dudognon E; Caron V
    J Pharm Sci; 2007 May; 96(5):1398-407. PubMed ID: 17455353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid state amorphization of pharmaceuticals.
    Willart JF; Descamps M
    Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trehalose amorphization and recrystallization.
    Sussich F; Cesàro A
    Carbohydr Res; 2008 Oct; 343(15):2667-74. PubMed ID: 18768170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state transformation of different gabapentin polymorphs upon milling and co-milling.
    Lin SY; Hsu CH; Ke WT
    Int J Pharm; 2010 Aug; 396(1-2):83-90. PubMed ID: 20561572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
    Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
    Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives.
    Balani PN; Ng WK; Tan RB; Chan SY
    J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of wet milling process on the solid state of indomethacin and simvastatin.
    Sharma P; Denny WA; Garg S
    Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of budesonide nanocluster dry powder aerosols: preformulation.
    El-Gendy N; Selvam P; Soni P; Berkland C
    J Pharm Sci; 2012 Sep; 101(9):3434-44. PubMed ID: 22623018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
    Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
    Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
    Amharar Y; Curtin V; Gallagher KH; Healy AM
    Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ordering and disordering of molecular solids upon mechanical milling: the case of fananserine.
    De Gusseme A; Neves C; Willart JF; Rameau A; Descamps M
    J Pharm Sci; 2008 Nov; 97(11):5000-12. PubMed ID: 18702119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
    Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
    J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid state chemistry of proteins: I. glass transition behavior in freeze dried disaccharide formulations of human growth hormone (hGH).
    Pikal MJ; Rigsbee DR; Roy ML
    J Pharm Sci; 2007 Oct; 96(10):2765-76. PubMed ID: 17621677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.
    Sood J; Sapra B; Bhandari S; Jindal M; Tiwary AK
    Ther Deliv; 2014 Oct; 5(10):1123-42. PubMed ID: 25418270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic and Covalent Transformations of Gabapentin in Binary Excipient Mixtures after Milling-Induced Stress.
    Tinmanee R; Stamatis SD; Ueyama E; Morris KR; Kirsch LE
    Pharm Res; 2018 Feb; 35(2):39. PubMed ID: 29392513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy-based analysis of cone milling process for the comminution of roller compacted flakes.
    Samanta AK; Wang L; Ng KY; Heng PW
    Int J Pharm; 2014 Feb; 462(1-2):108-14. PubMed ID: 24374608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
    Kayaert P; Van den Mooter G
    Eur J Pharm Biopharm; 2012 Aug; 81(3):650-6. PubMed ID: 22579733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.